NRG-GI003
Closed to Accrual & Treatment
Protocol Information
A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma
Principal Investigator
Status
Closed to Accrual & Treatment
Open to Accrual
June 21, 2017
Closed to Accrual
January 14, 2026
Closed to Accrual & Treatment
January 14, 2026
Disease Site
Gastrointestinal [GI] Liver
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine if overall survival (OS) is different for hepatocellular carcinoma patients treated with protons compared to photons.
Patient Population
Patients with pathologically (histologically or cytologically) or radiographically proven (based on the American Association for the Study of Liver Diseases criteria) unresectable or locally recurrent hepatocellular cancer
Target Accrual
167
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
To learn more about this study, visit the Patient Study Webpage.
-
Share this study.
-
-
-
-
